🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to complete the total safety database size for...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-07-19
Trial ID
NCT03954743
The purpose of this study is to evaluate the immunogenicity, reactogenicity...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-02-20
Trial ID
NCT02141204
Treatments Being Tested
This study is planned to evaluate the safety (in terms of occurrence of any...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-01-25
Trial ID
NCT00420745
The Phase I clinical trial of the oral hexavalent reassortant rotavirus att...
Status
Completed
Location
Hebei Provincial Center for Disease Control and Prevention
Start Date
2024-03-27
Trial ID
NCT06950645
This protocol posting deals with objectives and outcome measures of the pri...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-09-02
Trial ID
NCT00750893
Treatments Being Tested
Primary Objective: To demonstrate the non-inferiority of the SHAN6™ vaccin...
Status
Completed
Location
Investigational Site Number 7640003
Start Date
2020-06-28
Trial ID
NCT04429295
Treatments Being Tested
The main objective of this study is to provide immunogenicity data for GSK ...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-06
Trial ID
NCT00139334
Treatments Being Tested
This study is conducted to demonstrate non-inferiority in the immunogenicit...
Status
Completed
Location
CDC Nam Dinh
Start Date
2019-03-16
Trial ID
NCT03703336
Treatments Being Tested
The primary objective of this study is to determine if the GSK Biologicals'...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-10
Trial ID
NCT00241644
The Phase II clinical trial of the oral hexavalent reassortant rotavirus at...
Status
Recruiting
Location
Hubei Provincial Center for Disease Control and Prevention
Start Date
2025-01-20
Trial ID
NCT06967272